To characterize their individual impacts on AICDA expression, we next stimulated four BCP-ALL cell lines (RS4;11, TOM1, SD1, and Nalm6) with combinations of CD40L, IL-13, and TGFβ (Fig. 2c, d). The gene discussed is IL13; the disease is acute lymphoblastic leukemia.